Galena Biopharma Launches Zuplenz Oral Soluble Film

Galena Biopharma, Inc.

today announced the product launch for Zuplenz® (ondansetron) Oral Soluble Film in the United States. Zuplenz is now available nationwide and is supplied in both 4 mg and 8 mg strengths. Zuplenz is clinically bioequivalent to ondansetron orally disintegrating tablets (ODT) with a safety profile equivalent to ondansetron. The novel, PharmFilm® oral soluble film technology utilized by Zuplenz provides for convenient delivery and several key patient benefits including: Rapidly dissolves in the mouth in about 10 seconds Eliminates the burden of swallowing pills during emesis and in cases of oral irritation Does not require water to administer Pleasant peppermint flavor with no gritty aftertaste Non-sedating "Ondansetron is the gold-standard treatment option for patients suffering from nausea and vomiting due to chemotherapy, radiation treatments, and surgical procedures; and, we believe the unique and innovative product attributes of Zuplenz will be a